ITGR Integer Holdings Corp
Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1114483 · Fiscal year ends 12/31
Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.3%
TTM net income YoY19.3%
TTM EPS YoY22.7%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR8.0%
Margins
Gross margin24.6%
Operating margin8.2%
Net margin5.7%
FCF margin4.5%
EBITDA margin15.9%
Returns
ROE6.0%
ROA3.1%
ROIC (approx.)5.0%
Asset turnover0.54x
Leverage & solvency
Liabilities / assets49.1%
Debt / equity0.71x
Current ratio3.98x
Interest coverage3.87x
Cash quality & payout
Operating cash flow / net income1.70x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue5.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.85B | $1.72B | $1.56B | $1.33B | $1.22B |
| Cost of revenue | $1.35B | $1.26B | $1.15B | $985.52M | $884.11M |
| Gross profit | $500.39M | $459.01M | $409.89M | $345.76M | $336.97M |
| R&D expense | $49.50M | $53.42M | $61.97M | $59.76M | $51.98M |
| SG&A expense | $211.75M | $185.20M | $173.17M | $158.05M | $141.42M |
| Operating income | $221.26M | $208.24M | $163.32M | $112.68M | $135.71M |
| Interest expense | $43.21M | $56.37M | $51.27M | $37.27M | $31.63M |
| Pretax income | $125.40M | $147.56M | $105.38M | $68.68M | $101.06M |
| Income tax | $22.57M | $26.51M | $16.24M | $8.93M | $8.04M |
| Net income | $102.81M | $119.90M | $90.65M | $66.38M | $96.81M |
| EBITDA | $351.93M | $319.27M | $262.16M | $204.67M | $217.08M |
| EPS (basic) | 2.96 | 3.57 | 2.72 | 2.00 | 2.93 |
| EPS (diluted) | 2.89 | 3.36 | 2.69 | 1.99 | 2.91 |
| Weighted avg. shares (diluted) | 35.59M | 35.65M | 33.76M | 33.36M | 33.26M |
| Balance sheet | |||||
| Cash & equivalents | $17.16M | $46.54M | $23.67M | $24.27M | $17.89M |
| Receivables | $346.08M | $245.27M | $231.28M | $224.32M | $182.31M |
| Inventory | $253.74M | $247.13M | $229.10M | $208.77M | $155.70M |
| Current assets | $770.10M | $671.12M | $617.67M | $558.30M | $452.98M |
| PP&E, net | $536.43M | $465.80M | $392.57M | $317.24M | $277.10M |
| Goodwill | $1.11B | $1.02B | $994.01M | $965.19M | $924.70M |
| Intangibles | $825.43M | $778.29M | $779.60M | $819.89M | $807.81M |
| Total assets | $3.41B | $3.08B | $2.94B | $2.79B | $2.58B |
| Current liabilities | $232.04M | $227.17M | $220.97M | $223.75M | $159.63M |
| Short-term debt | $0 | $10.00M | $0 | $18.19M | $15.25M |
| Long-term debt | $1.19B | $980.15M | $959.92M | $907.07M | $812.88M |
| Total debt | $1.19B | $990.15M | $959.92M | $925.26M | $828.13M |
| Total liabilities | $1.66B | $1.46B | $1.42B | $1.38B | $1.23B |
| Shareholders' equity | $1.75B | $1.62B | $1.52B | $1.42B | $1.35B |
| Net debt | $1.17B | $943.61M | $936.25M | $900.99M | $810.24M |
| Shares outstanding | 34.35M | 33.55M | 33.33M | 33.17M | 33.06M |
| Cash flow statement | |||||
| Operating cash flow | $196.15M | $205.21M | $180.21M | $116.38M | $156.67M |
| Capital expenditure | $91.03M | $105.36M | $119.94M | $74.73M | $53.46M |
| Free cash flow | $105.12M | $99.85M | $60.27M | $41.65M | $103.20M |
| Investing cash flow | -$270.73M | -$195.41M | -$163.37M | -$200.42M | -$271.00M |
| Financing cash flow | $43.56M | $13.32M | -$18.01M | $92.48M | $81.99M |
| Depreciation & amortization | $130.67M | $111.03M | $98.84M | $91.99M | $81.37M |
| Stock-based compensation | $23.22M | $24.77M | $23.28M | $21.02M | $16.18M |
| Share buybacks | $50.01M | $0 | $0 | — | — |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.